Dr Paul Griffin

Paul Griffin is the Medical Doctor and one of the independent committee members for the CNS Institute BioSafety Committee (IBC).  Paul is a practicing infectious diseases physician and clinical microbiologist and has a broad background in infectious diseases and clinical research.

Paul is a Senior Lecturer in Medicine and Director of Infectious Diseases at the University of Queensland and Mater Hospitals, South Brisbane, Australia. He is the Principal Investigator and Manager of Medical Services at QPharm Pty Ltd; a specialized contract research organisation within the Queensland Institute of Medical Research (QIMR) Berghofer specializing in early and late phase trials in infectious diseases where he has been the Principal Investigator for > 25 clinical trials. Concurrently he maintains a joint appointment as a scientist at QIMR Berghofer/Mater Medical Research Institute with a primary research interest in tropical medicine particularly malaria human challenge and transmission blocking studies. Finally as a practising clinical microbiologist he maintains an active interest in diagnostic microbiology with a focus on the detection of antibiotic resistance particularly for Vancomycin Resistant enterococcus (VRE) with matrix-assisted laser desorption/ionisation time of flight (MALDI-TOF) mass spectrometry.

Paul has fellowships in infectious diseases from the Royal Australasian College of Physicians, in clinical microbiology from the Royal College of Pathologists of Australasia and from the Australasian College of Tropical Medicine.  He completed his Bachelor of Medicine and Surgery at the University of Queensland after successfully completing a Bachelor of Science (Honours) at the University of Adelaide with majors in microbiology, immunology and biochemistry. His research thesis considered cellular mechanisms of autoimmunity.